Riskpilot← Back to searchSign inGet full accessTumedkon Aktiebolag
ABActiveOrg 5561277640Parkvägen 6 KärdaOther human health activities n.e.c. · NACE 8699Est. 19691 employees
Revenue 2025
SEK 438K
+89% vs 2024
EBITDA margin
51.4%
+1355% vs 2024
Equity ratio
95.4%
Financial strength
Net profit 2025
SEK 213K
+22882% vs 2024
| Revenue | SEK 438K | +89% |
| EBITDA | SEK 225K | +1355% |
| Net profit | SEK 213K | +22882% |
| Total assets | SEK 2,9M | +3% |
| Equity | SEK 2,8M | +0% |
| Employees | 1 | — |
Legal name
Tumedkon Aktiebolag
Org number
5561277640
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
21 juli 1969
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva läkarpraktik, medicinsk konsultverksamhet, inköp och försäljning av damkonfektion och kosmetiska produkter, äga och förvalta aktier och andra värdepapper samt idka därmed förenlig verksamhet.
Address
Parkvägen 6 Kärda
Phone
+4637027046
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 528 | 1 025 | 697 | 232 | 438 |
| Staff expenses | — | −630 | −366 | −30 | −72 |
| EBITDA | 317 | 150 | 64 | −18 | 225 |
| Depreciation & amort. | −10 | −10 | −13 | −15 | −5 |
| EBIT | 307 | 140 | 52 | −33 | 220 |
| Net financials | 68 | 78 | 79 | 45 | 55 |
| Profit before tax | 375 | 218 | 131 | 12 | 275 |
| Tax | −79 | −47 | −28 | −11 | −62 |
| Net profit | 296 | 171 | 103 | 1 | 213 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 512 | 3 329 | 3 076 | 2 867 | 2 947 |
| Equity | 3 271 | 3 105 | 3 012 | 2 809 | 2 812 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 241 | 224 | 64 | 58 | 134 |
| Total debt | 241 | 224 | 64 | 58 | 134 |
EBITDA margin
51.4%
This company
15.8%
Market median
+225% vs market
20212025
Equity ratio
95.4%
This company
38.2%
Market median
+150% vs market
20212025
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20212025
Net profit margin
48.6%
This company
8.1%
Market median
+500% vs market
20212025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
EK | Audit | 2022 – 2022 |
RA Auditor Substitute | Auditor Substitute | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Tumedkon Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Kristina Skärström | Audit | 0 companies |
| Rickard Anders Uno Johansson | Auditor Substitute | 0 companies |
| Torben Ulvatne | Board of Directors | 0 companies |
| Karen Marie Ulvatne | Deputy Board Member | 0 companies |